Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: February 12, 2016


With Zika virus emerging as a public health concern worldwide, experts at The Johns Hopkins Hospital are closely monitoring the spread of the mosquito-borne illness and offering useful information to help prevent transmission.

Released: February 10, 2016


A new study led by Johns Hopkins researchers concludes that people with medically serious weight problems can rarely find or have access to proven, reliable programs to help them shed pounds.

Released: February 8, 2016


Johns Hopkins recently received approval from the United Network for Organ Sharing to be the first hospital in the U.S. to perform HIV-positive to HIV-positive organ transplants. The institution will be the first in the nation to do an HIV-positive to HIV-positive kidney transplant and the first in the world to execute an HIV-positive to HIV-positive liver transplant.

Released: February 4, 2016


 
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. A report on the study is published in the February issue of Cancer Prevention Research.
Released: February 2, 2016


David J. McConkey, Ph.D., has been appointed director of the Johns Hopkins Greenberg Bladder Cancer Institute, whose members include experts from the Sidney Kimmel Comprehensive Cancer Center, the James Buchanan Brady Urological Institute, and the school of medicine’s departments of Radiation Oncology and Molecular Radiation Sciences, Surgery, and Pathology.

Released: February 1, 2016

Traveling cells may be intrinsically resistant to chemotherapy, cell study suggests


There’s apparently safety in numbers, even for cancer cells. New research in mice suggests that cancer cells rarely form metastatic tumors on their own, preferring to travel in groups since collaboration seems to increase their collective chances of survival, according to researchers at Johns Hopkins.

Released: February 1, 2016


Researchers at Johns Hopkins and the Henry Ford Health System report evidence that higher levels of physical fitness may not only reduce risk of heart attacks and death from all causes, but also possibly improve the chances of survival after a first attack.

Released: January 29, 2016


Researchers at Johns Hopkins say an online “pop quiz” they developed in 2009 shows promising accuracy in predicting sexually transmitted infections (STIs) in young women, although not, apparently, in young men.

Released: January 28, 2016


When practicing and learning a new skill, making slight changes during repeat practice sessions may help people master the skill faster than practicing the task in precisely the same way, Johns Hopkins researchers report.

Released: January 28, 2016


During an animal’s embryonic development, a chemical chain reaction known as Hippo directs organs to grow to just the right size and no larger. Now Johns Hopkins researchers working with laboratory flies report that this signaling pathway also plays a role in revving up the insects’ immune systems to combat certain bacterial infections.

Released: January 19, 2016

3-D structures could lead to more potent fluoroquinolones for the fight against other disease-causing bacteria too


Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.

Released: January 19, 2016

Compound counteracts the process


Working with mice, researchers at Johns Hopkins have contributed significant new evidence to support the idea that high doses of cocaine kill brain cells by triggering overactive autophagy, a process in which cells literally digest their own insides. Their results, moreover, bring with them a possible antidote, an experimental compound dubbed CGP3466B.

Released: January 13, 2016


Kathy DeRuggiero, R.N., D.N.P., a 32-year Johns Hopkins Medicine nursing veteran and leader, has been named vice president of patient services for Johns Hopkins Medicine International.

Released: January 12, 2016

Compound already tested in humans for other purposes and found nontoxic


The compound CGP3466B, already proven nontoxic for people, may effectively and rapidly treat depression, according to results of a study in mice.

Released: January 7, 2016

Researchers show that stroke conditions may increase brain plasticity and recovery in some cases


Using mice whose front paws were still partly disabled after an initial induced stroke, Johns Hopkins researchers report that inducing a second stroke nearby in their brains let them “rehab” the animals to successfully grab food pellets with those paws at pre-stroke efficiency.

Released: January 6, 2016


The Johns Hopkins University and Johns Hopkins Medicine will celebrate Martin Luther King Jr.’s life and legacy of justice, equality and peaceful activism.

Released: January 5, 2016

Preliminary study suggests new rules also increased transplantation rates for adults under 50 but significantly lowers them in those over 50


Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.

Released: December 30, 2015


Taking a high dose of vitamin D3 is safe for people with multiple sclerosis and may help regulate the body’s hyperactive immune response, according to a pilot study published by Johns Hopkins physicians in the Dec. 30 online issue of Neurology, the medical journal of the American Academy of Neurology.

Released: December 28, 2015

Marmosets shed light on our evolutionary history, become model for studying musical ability and tone deafness


The specialized human ability to perceive the sound quality known as “pitch” can no longer be listed as unique to humans. Researchers at Johns Hopkins report new behavioral evidence that marmosets, ancient monkeys, appear to use auditory cues similar to humans to distinguish between low and high notes. The discovery infers that aspects of pitch perception may have evolved more than 40 million years ago to enable vocal communication and songlike vocalizations.

Released: December 23, 2015

Short daily exposure to “asynchrony” using a pacemaker may jump-start a suite of recovery mechanisms, experiments suggest


Johns Hopkins has demonstrated in animals that applying a pacemaker’s mild electrical shocks to push the heart in and out of normal synchronized contraction for part of each day may be an effective way to slow down the progression of heart failure, a disorder that afflicts millions of Americans.”